Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Cash & Equivalents (2016 - 2025)

Myomo (MYO) has disclosed Cash & Equivalents for 10 consecutive years, with $12.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 79.4% year-over-year to $12.6 million, compared with a TTM value of $12.6 million through Sep 2025, up 79.4%, and an annual FY2024 reading of $24.7 million, up 260.16% over the prior year.
  • Cash & Equivalents was $12.6 million for Q3 2025 at Myomo, down from $15.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $24.7 million in Q4 2024 and bottomed at $5.3 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $11.5 million, with a median of $10.2 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents tumbled 65.56% in 2022, then skyrocketed 264.21% in 2025.
  • Year by year, Cash & Equivalents stood at $15.5 million in 2021, then crashed by 65.56% to $5.3 million in 2022, then increased by 28.53% to $6.9 million in 2023, then soared by 260.16% to $24.7 million in 2024, then tumbled by 49.27% to $12.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for MYO at $12.6 million in Q3 2025, $15.5 million in Q2 2025, and $19.8 million in Q1 2025.